116 related articles for article (PubMed ID: 3080328)
1. Trypanosoma cruzi: ultrastructural changes produced by an anti-trypanosomal factor from Pseudomonas fluorescens.
Mercado TI; Butany JW; Ferrans VJ
Exp Parasitol; 1986 Feb; 61(1):65-75. PubMed ID: 3080328
[TBL] [Abstract][Full Text] [Related]
2. Effect of Crotalus viridis viridis snake venom on the ultrastructure and intracellular survival of Trypanosoma cruzi.
Adade CM; Cons BL; Melo PA; Souto-Padrón T
Parasitology; 2011 Jan; 138(1):46-58. PubMed ID: 20663246
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
Lazardi K; Urbina JA; de Souza W
Antimicrob Agents Chemother; 1990 Nov; 34(11):2097-105. PubMed ID: 2073100
[TBL] [Abstract][Full Text] [Related]
4. 4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi.
Britta EA; Scariot DB; Falzirolli H; da Silva CC; Ueda-Nakamura T; Dias Filho BP; Borsali R; Nakamura CV
Parasitology; 2015 Jun; 142(7):978-88. PubMed ID: 25711881
[TBL] [Abstract][Full Text] [Related]
5. Biological approaches to characterize the mode of action of two 5-nitroindazolinone prototypes on Trypanosoma cruzi bloodstream trypomastigotes.
Fonseca-Berzal C; DA Silva CF; Menna-Barreto RF; Batista MM; Escario JA; Arán VJ; Gómez-Barrio A; Soeiro Mde N
Parasitology; 2016 Sep; 143(11):1469-78. PubMed ID: 27312370
[TBL] [Abstract][Full Text] [Related]
6. Trypanocidal action of eupomatenoid-5 is related to mitochondrion dysfunction and oxidative damage in Trypanosoma cruzi.
Pelizzaro-Rocha KJ; Veiga-Santos P; Lazarin-Bidóia D; Ueda-Nakamura T; Dias Filho BP; Ximenes VF; Silva SO; Nakamura CV
Microbes Infect; 2011 Nov; 13(12-13):1018-24. PubMed ID: 21683800
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations and peroxide formation induced by naphthoquinones in different stages of Trypanosoma cruzi.
Docampo R; De Souza W; Cruz FS; Roitman I; Cover B; Gutteridge WE
Z Parasitenkd; 1978 Nov; 57(3):189-98. PubMed ID: 216177
[TBL] [Abstract][Full Text] [Related]
8. Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.
Lechuga GC; Borges JC; Calvet CM; de Araújo HP; Zuma AA; do Nascimento SB; Motta MCM; Bernardino AMR; Pereira MCS; Bourguignon SC
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):154-164. PubMed ID: 27490082
[TBL] [Abstract][Full Text] [Related]
9. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction.
Menna-Barreto RF; Goncalves RL; Costa EM; Silva RS; Pinto AV; Oliveira MF; de Castro SL
Free Radic Biol Med; 2009 Sep; 47(5):644-53. PubMed ID: 19501647
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of adamantylidene-substituted alkylphosphocholine TCAN26 against Trypanosoma cruzi: Antiproliferative and ultrastructural effects.
Barrias E; Reignault LC; Calogeropoulou T; de Souza W
Exp Parasitol; 2019 Nov; 206():107730. PubMed ID: 31494215
[TBL] [Abstract][Full Text] [Related]
11. Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study.
Menna-Barreto RF; Salomão K; Dantas AP; Santa-Rita RM; Soares MJ; Barbosa HS; de Castro SL
Micron; 2009 Feb; 40(2):157-68. PubMed ID: 18849169
[TBL] [Abstract][Full Text] [Related]
12. In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea.
Veiga-Santos P; Pelizzaro-Rocha KJ; Santos AO; Ueda-Nakamura T; Dias Filho BP; Silva SO; Sudatti DB; Bianco EM; Pereira RC; Nakamura CV
Parasitology; 2010 Sep; 137(11):1661-70. PubMed ID: 20546638
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect and ultrastructural changes in Trypanosoma cruzi caused by isoobtusilactone A in short exposure of time.
de Almeida JM; Nunes FO; Ceole LF; Klimeck TDF; da Cruz LA; Tófoli D; Borges BS; Garcez WS; Tozetti IA; Medeiros LCS; Garcez FR; Ferreira AMT
PLoS One; 2021; 16(1):e0245882. PubMed ID: 33507972
[TBL] [Abstract][Full Text] [Related]
14. Butenolides from Nectandra oppositifolia (Lauraceae) displayed anti-Trypanosoma cruzi activity via deregulation of mitochondria.
Conserva GAA; da Costa-Silva TA; Amaral M; Antar GM; Neves BJ; Andrade CH; Tempone AG; Lago JHG
Phytomedicine; 2019 Feb; 54():302-307. PubMed ID: 30668381
[TBL] [Abstract][Full Text] [Related]
15. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
[TBL] [Abstract][Full Text] [Related]
16. Cellular effects of reversed amidines on Trypanosoma cruzi.
Silva CF; Meuser MB; De Souza EM; Meirelles MN; Stephens CE; Som P; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2007 Nov; 51(11):3803-9. PubMed ID: 17698624
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi.
Santa-Rita RM; Barbosa HS; de Castro SL
Parasitol Res; 2006 Dec; 100(1):187-90. PubMed ID: 16855821
[TBL] [Abstract][Full Text] [Related]
18. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study.
De Carvalho EA; Andrade PP; Silva NH; Pereira EC; Figueiredo RC
Micron; 2005; 36(2):155-61. PubMed ID: 15629646
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi.
Luize PS; Ueda-Nakamura T; Dias Filho BP; Cortez DA; Morgado-Díaz JA; de Souza W; Nakamura CV
Parasitol Res; 2006 Dec; 100(1):31-7. PubMed ID: 16783543
[TBL] [Abstract][Full Text] [Related]
20. Disruption of mitochondrial function as the basis of the trypanocidal effect of trifluoperazine on Trypanosoma cruzi.
Lacuara JL; de Barioglio SR; de Oliva PP; Bernacchi AS; de Culasso AF; Castro JA; Franke de Cazzulo BM; Cazzulo JJ
Experientia; 1991 Jun; 47(6):612-6. PubMed ID: 1829686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]